BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16197397)

  • 1. Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gel.
    Dawe SA; Salisbury JR; Higgins E
    Clin Exp Dermatol; 2005 Nov; 30(6):712-3. PubMed ID: 16197397
    [No Abstract]   [Full Text] [Related]  

  • 2. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
    Patel MJ; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():53-6. PubMed ID: 17488408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
    Burkhart CN; Burkhart CG
    Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
    Gracia-Cazaña T; López MT; Oncins R; Gilaberte Y
    Dermatol Ther; 2015; 28(6):341-3. PubMed ID: 26291609
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreens.
    Ortonne JP; Queille-Roussel C; Duteil L
    Eur J Dermatol; 2006; 16(4):385-90. PubMed ID: 16935795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Rivers JK
    Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis.
    Maltusch A; Röwert-Huber J; Matthies C; Lange-Asschenfeldt S; Stockfleth E
    J Dtsch Dermatol Ges; 2011 Dec; 9(12):1011-7. PubMed ID: 21585654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach.
    Graham BD; Jetmore AB; Foote JE; Arnold LK
    Dis Colon Rectum; 2005 Mar; 48(3):444-50. PubMed ID: 15747068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowen's disease of the nipple-a new method of treatment.
    Brookes PT; Jhawar S; Hinton CP; Murdoch S; Usman T
    Breast; 2005 Feb; 14(1):65-7. PubMed ID: 15695084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
    Usmani N; Stables GI; Telfer NR; Stringer MR
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Bowen's disease with photodynamic therapy after Imiquimod: the need for controlled trials.
    Vereecken P; Heenen M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1397-9. PubMed ID: 17062104
    [No Abstract]   [Full Text] [Related]  

  • 14. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.
    Pirard D; Vereecken P; Mélot C; Heenen M
    Arch Dermatol Res; 2005 Nov; 297(5):185-9. PubMed ID: 16235081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil cream and leg ulceration.
    Duncan AL; Bell HK
    J Plast Reconstr Aesthet Surg; 2007; 60(6):690-1. PubMed ID: 17485063
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of Bowen's disease with ingenol mebutate 0.05% gel.
    Lee JH; Lee JH; Bae JM; Kim GM
    J Dermatol; 2015 Sep; 42(9):920-1. PubMed ID: 25983016
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
    Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
    Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa.
    Souza CS; Felício LB; Bentley MV; Tedesco AC; Ferreira J; Kurachi C; Bagnato VS
    Br J Dermatol; 2005 Sep; 153(3):672-4. PubMed ID: 16120168
    [No Abstract]   [Full Text] [Related]  

  • 19. Diclofenac gel for osteoarthritis.
    Med Lett Drugs Ther; 2008 Apr; 50(1284):31-2. PubMed ID: 18425055
    [No Abstract]   [Full Text] [Related]  

  • 20. Ingenol mebutate gel for the treatment of Bowen's disease: a case report of three patients.
    Salleras Redonnet M; Quintana Codina M
    Dermatol Ther; 2016 Jul; 29(4):236-9. PubMed ID: 26969886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.